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ABSTRACT:	 With	 a	 mass	 of	 ~1.6	 x	 107	 Daltons	 and	 com-
posed	of	approximately	2700	proteins,	bacteriophage	M13	has	
been	 employed	 as	 a	molecular	 scaffold	 in	 bionanomaterials	
fabrication.	 In	 order	 to	 extend	 the	 versatility	 of	M13	 in	 this	
area,	 residue-specific	 unnatural	 amino	 acid	 incorporation	
was	employed	to	successfully	display	azide	functionalities	on	
specific	 solvent-exposed	positions	of	 the	pVIII	major	 sheath	
protein	 of	 this	 bacteriophage.	 Employing	 a	 combination	 of	
engineered	mutants	of	the	gene	coding	for	the	pVIII	protein,	
the	 methionine	 (Met)	 analog,	 L-azidohomoalanine	 (Aha),	
and	a	suitable	Escherichia	coli	Met	auxotroph	for	phage	pro-
duction,	conditions	were	developed	to	produce	M13	bacteri-
ophage	 labeled	 with	 over	 350	 active	 azides	 (estimated	 by	
fluorescent	 dye	 labeling	 utilizing	 a	 strain-promoted	 azide-
alkyne	 cycloaddition)	 and	 capable	 of	 azide-selective	 attach-
ment	 to	 5	nm	gold	nanoparticles	 as	 visualized	by	 transmis-
sion	 electron	 microscopy.	 The	 capability	 of	 this	 system	 to	
undergo	dual	 labeling	utilizing	both	chemical	acylation	and	
bioorthogonal	cycloaddition	reactions	was	also	verified.	The	
above	 stratagem	 should	 prove	 particularly	 advantageous	 in	
the	 preparation	 of	 assemblies	 of	 larger	 and	 more	 complex	
molecular	architectures	based	on	the	M13	building	block.	
Viral	scaffolds	are	receiving	intense	interest	for	their	use	in	
materials	and	bionanomaterials1–16.	Owing	to	its	well-defined	
architecture	 and	 the	 ability	 to	 finely	 control	 its	 structure	
through	 molecular	 biological17–19	 as	 well	 as	 chemical	 meth-
ods20–23,	bacteriophage	M13	has	been	employed	 in	 the	 fabri-
cation	of	bionano-wires10,	 functional	biomaterials4–9,	sensors	
or	 probes1,12,15,	 and	 bioelectronic	 devices	 such	 as	 solar	 cells	
and	 piezoelectric	 biobatteries3,5,7,13.	 This	 filamentous	 virus	
(dimensions	 of	 approximately	 6	 nm	 x	 900	 nm),	 specific	 for	
Escherichia	 coli,	 is	 self-assembled	 at	 the	 bacterial	
membrane19,24.	The	mature	bacteriophage	is	composed	of	five	
copies	 of	 each	of	 four	different	 tip	proteins:	 pIII,	 pVI,	 pVII,	
pIX,	 and	 approximately	 2700	 copies	 of	 the	major	 coat	 pro-
tein,	pVIII,	which	 is	helically	 arranged	around	 the	encapsu-
lated	 viral	 DNA	 genome	 (Figure	 1)21,25.	 Modification	 of	M13	
with	 unnatural	 amino	 acids	 (UAA)	 has	 been	 accomplished	
on	 the	 pIII	 coat	 protein	 for	 phage	 display	 applications,	 alt-
hough	these	studies	did	not	assess	the	extent	of	UAA	incor-
poration	into	M13	itself17,19,26,27.	Given	the	relatively	low	copy	
number	 of	 pIII	 subunits	 per	M13	 phage,	 more	 highly	 func-
tionalized	 nano-scale	 materials	 could	 result	 from	 the	 engi-
neering	 of	 the	major	 coat	 protein	 pVIII	without	 perturbing	
the	 pIII	 protein,	 a	 common	 site	 for	 the	 display	 of	 peptides	
having	affinities	to	xenomaterials.	For	(bio)materials	applica-
tions	of	M13,	knowledge	of	the	extent	of	UAA	incorporation	
into	M13	and	the	development	of	a	system	for	multiple	label-
ing	capabilities	are	also	essential.	
To	achieve	this,	we	show	that	the	residue	specific	incorpo-
ration	of	L-azidohomoalanine	(Aha),	an	analog	of	the	amino	
acid	methionine	(Met),	into	Met	positions	in	pVIII	is	possible	
when	 infecting	 a	Met	 auxotrophic	 strain	 of	 E.	 coli	 (ER2738	
metE)	with	engineered	variants	of	M13	under	specific	media	
conditions.	E.	coli	strain	ER2738	was	utilized	to	provide	the	F’	
required	 for	M13	 infection.	As	well,	 inactivation	of	 the	metE	
gene	 (ΔmetE774::kan)	 in	 ER2738	 was	 constructed	 by	 P1vir	
transduction	to	block	E.	coli	Met	biosynthesis	and	eliminate	
competition	 from	endogenously	biosynthesized	methionine.	
Successful	labeling	of	pVIII	utilizing	the	displayed	azide	was	
accomplished	using	strain-promoted	azide-alkyne	cycloaddi-
tion	(SPAAC;	Figure	1)28.	The	pVIII	protein	is	highly	tolerant	
to	mutagenesis	and	contains	only	a	 few	epitopes	 that	 result	
in	a	large	loss	of	viability	when	changed29.	Constructing	sev-
eral	 variants	 of	 M13	 that	 repositioned	 a	 Met	 residue	 (and	
therefore	 the	 Aha	 analog)	 for	 optimum	 solvent	 exposure	
enhanced	 the	 availability	 of	 this	 azide	 group	 for	phage	 sur-
face	modification	on	the	mature	pVIII	coat	protein	(Figure	1).	
Of	 the	 three	 Met	 residues	 present	 in	 pro-pVIII,	 two	 are	
removed	 by	 the	 host	 E.	 coli	 leader	 peptidase	 before	 phage	
extrusion	(Figure	1).	The	Met	residues	at	positions	-5	and	28	
were	 replaced	by	 leucines	prior	 to	 substituting	Met	at	posi-
tion	9	(M13A9M),	 13	 (M13S13M)	or	 16	 (M13A16M)	by	recombinant	
DNA	 techniques	 in	 order	 to	 counter	 any	 possible	 effects	 in	
phage	 production	 levels	 caused	 by	 substitutions	 by	 Aha	 at	
these	 non-strategic	 Met	 positions	 in	 pVIII.	 Net	 phage	 pro-
duction	for	each	variant	was	compared	with	that	of	WT	M13	
(M13WT)	at	4.5	hours	 in	order	 to	obtain	a	measure	of	phage	
viability.	The	M13	variants	produced	under	 these	conditions	
resulted	in	some	loss	of	viability	ranging	from	3.0-fold	to	7.7-
fold	 compared	 to	M13WT	 (Supplementary	 Figure	 1a).	 Of	 the	
three	 single	 Met	 variants,	 M13A16M	 viability	 was	 the	 lowest.	
The	A16M	mutation	might	interfere	with	the	stacking	of	ad-
jacent	pVIII	subunits	compared	to	positions	A9	and	S13	that	
are	more	exposed	in	the	N-terminal	region	of	pVIII.	In	a	ran-
domized	mutagenesis	 study	 on	 pVIII,	 the	 positions	 A9,	 S13	
 and	A16	were	found	to	be	highly	variable30.	The	mutability	of	
pVIII	 was	 consistent	 with	 the	 good	 yields	 of	 variants	 pro-
duced	in	this	current	study.		
	
Figure	1:	(a)	Scheme	showing	the	production	of	M13	phages	
with	Aha	and	 the	modification	of	 azide-containing	M13.	 (b)	
Molecular	 structure	 (PDB:	 2MJZ)	 of	 pVIII	 coat	 protein	 as-
sembly	 showing	 the	position	of	A9,	 S13	 and	A16	 residues	 in	
purple	and	M28	in	yellow25.	(c)	Amino	acid	sequence	of	pVIII	
pro-coat	 protein	 with	 residues	 mutated	 in	 this	 study	 high-
lighted	 in	 bold.	 The	 leader	 peptidase	 cleavage	 site	 is	 also	
shown.	 (d)	 General	 scheme	 for	 the	 SPAAC	 reaction	 and	
bioorthogonal	labeling	agents	utilized	in	this	work.	
With	 the	 availability	 of	 several	 viable	 bacteriophage	 vari-
ants	containing	relocated	Met	positions	on	their	 surface	ex-
posed	pVIII	proteins,	investigations	on	unnatural	amino	acid	
bioincorporation	 into	 pVIII	 were	 undertaken.	 It	 has	 been	
established	that	Aha	can	compete	with	Met	and	be	charged	
onto	 tRNA	 by	methionyl-tRNA	 synthetase31.	 Notably,	 when	
an	amino	acid	auxotrophic	strain	of	E.	coli	is	grown	in	media	
containing	 the	 UAA	 of	 interest,	 incorporation	 of	 the	 UAA	
occurs31–35.	 Additionally,	 recent	metabolic	 engineering	 work	
has	demonstrated	that	Aha	can	be	intracellularly	produced36.	
The	added	challenge	of	incorporation	of	Aha	into	M13	during	
the	 process	 of	 phage	 infection	 and	 replication,	 which	 in-
cludes	 the	 complex	 production	 of	 eleven	 different	 phage	
proteins	(pI-pXI),	some	of	which	are	not	components	of	the	
mature	 M13	 phage	 but	 are	 required	 to	 be	 functional,	 was	
successfully	met	by	optimization	of	both	Aha	and	Met	levels	
in	the	bacterial	growth	medium	(Supplementary	Figure	1).		
Incorporation	 of	 Aha	 into	 pVIII	 was	 confirmed	 by	 elec-
trospray	 ionization	mass	 spectrometry	 (ESI-MS).	 The	major	
mass	 peak	 (5279	 Da)	 observed	 for	 pVIII	 in	 a	 spectrum	 of	
M13A9M	grown	in	the	absence	of	Aha	was	consistent	with	the	
theoretical	mass	of	pVIIIA9M	(5280	Da;	Figure	2	and	Supple-
mentary	Figure	2).	When	M13A9M	was	produced	 in	 the	pres-
ence	 of	 10	mM	Aha	 and	 235	 µM	Met,	 an	 additional	 protein	
with	a	mass	of	5274	Da	was	observed	which	corresponded	to	
the	 expected	 mass	 of	 pVIIIA9M	 containing	 Aha	 (Figure	 2).	
This	expected	mass	difference	of	-5	Da	was	also	observed	in	
the	 mass	 spectra	 of	 pVIIIS13M	 and	 pVIIIWT	 analyzed	 from	
phage	that	were	grown	in	the	presence	of	Aha	(Supplemen-
tary	Figures	3	and	4).	The	relative	intensities	of	the	Aha-pVIII	
peaks	were	 10-13%	 of	 the	Met-pVIII	 peak	 in	 each	 case.	 The	
negative	control,	M13M-5/28L,	 lacked	the	associated	peak	at	-5	
Da	 from	 the	major	 pVIII	 peak	 (Supplementary	 Figure	 5).	 A	
difference	in	mass	of	5	Da	is	only	consistent	with	Aha	substi-
tution.	As	there	is	only	a	single	Met	in	pVIIIWT,	pVIIIA9M	and	
pVIIIS13M,	Aha	is	expected	to	have	occurred	at	positions	28,	9	
and	13	on	pVIII	respectively.	
	
Figure	 2:	Deconvoluted	mass	 spectra	 for	M13A9M	 grown	 in	
the	 absence	 or	 presence	 of	 Aha	 from	 ESI-TOF	 MS	 experi-
ments.	As	pVIII	is	the	major	M13	protein,	mass	spectral	anal-
yses	 readily	 detect	 this	major	 component	 (a)	M13A9M	 grown	
without	Aha	 as	 outlined	 in	 the	Methods.	 (b)	M13A9M	 grown	
without	 Aha	 and	 then	 reacted	 with	 30	 µM	 DIBAC-PEG4-
TAMRA.	The	 inset	 shows	 the	portion	of	 the	 spectrum	 from	
5250	Da	 to	 5320	Da.	 (c)	M13A9M	 grown	with	 10	mM	Aha	 as	
outlined	in	the	methods.	(d)	M13A9M	grown	with	10	mM	Aha	
and	then	reacted	with	30	µM	DIBAC-PEG4-TAMRA.	The	 in-
set	shows	the	portion	of	the	spectrum	from	5250	Da	to	5320	
Da.	 	
Critical	 to	 future	applications	of	M13	as	 a	multivalent	na-
noparticle	 is	 the	 proof-of-concept	 of	 successfully	 applying	
bioorthogonal-labeling	 chemistries	 to	 the	 above	 Aha-
containing	 bacteriophage31,37.	 The	 SPAAC	 reaction	 was	 uti-
lized	here	with	an	aza-dibenzocycloocytne	(DIBAC)	reactive	
group,	which	was	 designed	 by	Debets,	M.F.	 and	 co-authors	
to	have	both	fast	kinetics	and	favourable	solubility	in	water28.	
Aha-containing	 M13	 was	 reacted	 with	 DIBAC-PEG4-
tetramethylrhodamine	 (DIBAC-PEG4-TAMRA)	 and	 the	 ab-
sorbance	spectra	of	the	labeled	phages	were	used	to	estimate	
the	 incorporation	efficiency	of	Aha.	Labeling	of	M13A9M	was	
confirmed	by	mass	spectrometry	experiments	(Figure	2).	The	
very	low	TAMRA	absorbance	in	phages	grown	in	the	absence	
of	 Aha	 indicated	 that	 the	washing	 procedure	 effectively	 re-
moved	non-specifically	bound	DIBAC-PEG4-TAMRA	(Figure	
3).	 The	 TAMRA-labeled	 M13	 phages	 exhibited	 a	 visible	 ab-
sorbance	spectrum	with	a	maximum	at	556	nm	and	a	shallow	
secondary	 maximum	 at	 518	 nm,	 corresponding	 to	 the	 ab-
sorbance	 of	 TAMRA38,39.	 M13A9M	 and	 M13S13M	 were	 labeled	
equally	well	at	14	±	2	%	and	13	±	2	%	respectively	and	suggest	
that	 13-14	%	of	pVIII	 subunits	had	Aha	 incorporated.	M13WT	
labeling	was	lower	at	5	±	1	%	of	pVIII	subunits	labeled.	M13WT	
was	 not	 expected	 to	 react	 to	 completion	 since	 structural	
studies	on	pVIII	have	indicated	that	Met28	which	is	present	
in	M13WT	 is	 not	 likely	 exposed	 to	 the	 solvent
40.	 Labeling	 of	
M13WT	 in	 this	 study	 could	 be	 attributed	 to	 the	 flexibility	 of	
M13	 itself	 allowing	exposure	of	a	 fraction	of	 the	Aha28	 resi-
dues	for	reaction41.	The	percentages	of	 incorporation	of	Aha	
estimated	here	were	similar	 to	 that	observed	 for	adenovirus	
coat	 protein	 labeling	 using	 a	 media	 replacement	 strategy,	
although	 in	 the	 current	 M13	 study	 an	 intact	 bacteriophage	
has	been	labeled42.	As	a	negative	control,	M13M-5/28L	grown	in	
10	mM	Aha	and	235	µM	Met	was	reacted	with	the	same	dye	
 (Figure	 3).	Using	 the	 same	mathematical	 treatment,	 the	 ex-
tent	of	labeling	was	estimated	at	1.4	±	1	%.	This	control	sug-
gests	 that	 labeling	 with	 DIBAC	 is	 specific	 to	 pVIII	 with	 an	
azide	 incorporated.	 Furthermore,	 it	 was	 expected	 that	 this	
labeling	strategy	would	be	orthogonal	to	other	common	pro-
tein	 labeling	 strategies.	 Indeed,	 when	 carried	 out	 together	
with	acylation	by	NHS-sulfo-cy7	(an	amine	specific	reagent),	
dual-labeling	of	M13A9M-Aha	with	both	dyes	occurred	as	ex-
pected.	For	A9M,	dual-labeling	was	observed	as	evidenced	by	
the	TAMRA	peak	at	556	nm	and	the	sulfo-cy7	peak	at	750	nm	
(Figure	3e).	Consistent	with	 the	other	 results	 for	SPAAC	 la-
beling	 of	M13	 the	 labeling	 efficiency	 of	DIBAC-TAMRA	was	
15.5	%	 for	 dual-labeled	M13.	 The	M13M-5/28L	 negative	 control	
did	 not	 react	 with	 DIBAC-TAMRA	 at	 all	 regardless	 of	 the	
growth	 conditions	 (Figure	 3f).	 As	 expected,	 NHS-sulfo-cy7	
reacted	 with	 both	 variants	 and	 regardless	 of	 whether	 they	
were	grown	in	the	presence	or	absence	of	Aha.	Dual-labeling	
on	single	M13	particles	was	also	verified	by	dual-labeling	fol-
lowed	by	affinity	isolation	experiments.	When	DIBAC-biotin	
was	reacted	alongside	NHS-sulfo-cy7	to	produce	dual-labeled	
A9M-Aha,	 the	 sulfo-cy7	 absorbance	 signal	 could	be	used	 to	
track	 separation	of	biotinylated	M13	using	 streptavidin	 (SA)	
magnetic	 particles	 (Supplemental	 Figures	 14	 and	 15).	 These	
additional	experiments	are	consistent	with	the	occurrence	of	
dual-labeling	 resulting	 in	 a	 population	 of	 M13	 conjugated	
with	two	different	labels	on	the	same	M13	particle.	
	
Figure	3:	Absorbance	spectra	of	M13	phages	grown	with	235	
µM	Met	in	the	presence	(10	mM)	or	absence	(0	mM)	of	Aha	
after	 labeling	 with	 DIBAC-PEG4-TAMRA.	 (a)	 M13A9M,	 (b)	
M13S13M,	(c)	M13WT,	or	(d)	M13M-5/28L	were	reacted	for	24	hours	
with	 30	 µM	 DIBAC-PEG4-TAMRA	 in	 1x	 PBS	 pH	 7.8.	 (e)	
M13A9M	or	(f)	M13M-5/28L	were	reacted	for	24	hours	with	30	µM	
DIBAC-PEG4-TAMRA	 and	 100	 µM	 NHS-sulfo-cy7	 in	 1x	 PBS	
pH	7.8.	Excess	dye	was	removed	using	a	10	kDa	spin	filtration	
column.	
	For	 visual	 inspection	 of	 bioorthogonal	 labeling	 using	
TEM,	M13	 variants	with	 displayed	 azides	were	 reacted	with	
DIBAC-PEG4-biotin	 and	 incubated	with	 streptavidin-labeled	
AuNPs	(SA-AuNPs).	Uniformity	of	distribution	of	AuNPs	was	
seen	 in	M13A9M	and	M13S13M	grown	with	 10	mM	Aha	and	235	
µM	Met	 (Supplementary	Figure	6	and	Figure	4).	When	bio-
tin-labeled	M13	 and	SA-AuNPs	were	 incubated	 together	 the	
average	 numbers	 of	 AuNPs	 observed	 bound	 to	 each	 phage	
particle	were	54	±	 19	and	57	±	 15	 for	M13A9M	and	M13S13M	re-
spectively	(Supplementary	Figure	7).	The	differences	in	con-
trast	seen	in	some	images	can	be	attributed	to	differences	in	
stain	 density	 between	 grid	 preparations.	 In	 the	 samples	
grown	in	the	absence	of	Aha,	a	small	number	of	AuNPs	can	
be	seen	associating	with	M13	phages,	but	substantially	fewer	
than	 the	 Aha-labeled	 phages	 (Figure	 4	 and	 Supplementary	
Figure	6).	In	M13WT,	as	the	azide	would	be	positioned	at	the	
interface	 between	 pVIII	 subunits,	 it	 is	 possible	 that	 adduct	
formation	 interferes	with	 the	 stability	 of	 assembled	M13.	 In	
this	regard	the	structures	of	M13WT	phages	post-reaction	ap-
peared	twisted	and	aggregated	(Supplementary	Figure	8).	As	
well,	 the	extent	of	M13WT	 labeling	was	much	 lower	 than	 for	
the	 M13A9M	 and	 M13S13M	 variants	 (Supplementary	 Figure	 7).	
The	 M13M-5/28L	 bacteriophage	 produced	 with	 Aha	 was	 only	
able	to	bind	6	±	3	AuNPs	per	phage	on	average,	likely	due	to	
non-specific	interactions	(Supplementary	Figure	9).	It	is	pos-
sible	that	the	number	of	associated	AuNPs	visualized	by	TEM	
under-represents	 the	 actual	 number	 of	 pVIII	 subunits	 with	
incorporated	 Aha.	 Due	 to	 the	 relatively	 large	 size	 of	 the	
AuNPs,	 it	 is	expected	that	not	all	Aha-pVIII	subunits	have	a	
AuNP	 associated	with	 them.	The	TEM	 results	were	 also	 re-
flected	in	the	mass	spectra	of	biotin-labeled	phages,	in	which	
only	for	M13A9M	and	M13S13M	could	the	biotin	label	be	detect-
ed	(Supplementary	Figures	10-13).		
	
Figure	4:	Transmission	electron	microscopy	(TEM)	images	
of	 M13S13M	 and	 M13WT	 constructs	 visualized	 with	 5	 nm	 SA-
AuNPs.	Non-specific	binding	was	blocked	with	 the	addition	
of	 0.1%	 BSA.	 (a)	 M13S13M	 grown	 in	 the	 absence	 of	 Aha	 and	
reacted	 with	 30	 µM	 DIBAC-PEG4-biotin	 followed	 by	 SA-
AuNP.	 (b)	M13S13M	grown	with	 10	mM	Aha/235	µM	Met	and	
reacted	 with	 30	 µM	 DIBAC-PEG4-biotin	 followed	 by	 SA-
AuNP.	 (c)	M13WT	 grown	 in	 the	 absence	 of	 Aha	 and	 reacted	
with	 30	 µM	 DIBAC-PEG4-biotin	 followed	 by	 SA-AuNP.	 (d)	
M13WT	grown	with	10	mM	Aha/235	µM	Met	and	reacted	with	
30	µM	DIBAC-PEG4-biotin	 followed	by	SA-AuNP.	White	ar-
rows	show	AuNPs	and	the	white	scale	bar	shows	100	nm.	
The	goal	of	 this	 research	was	 to	develop	an	enabling	M13	
bioincorporation	strategy	which	would	provide	labeling	sites	
capable	of	modification	by	methods	orthogonal	to	the	stand-
ard	 chemical	 labeling	 methods	 that	 have	 been	 previously	
utilized21.	 The	 research	 reported	 herein	 has	 successfully	
 demonstrated	 UAA	 incorporation	 into	 the	 pVIII	 protein	 of	
an	entire	bacteriophage	M13	and	has	demonstrated	the	capa-
bilities	 of	 these	 phages	 to	 be	 further	 modified,	 providing	
enhanced	versatility	 in	 a	 viral	 scaffold	which	 frequently	has	
been	 employed	 as	 a	 component	 in	 diverse	 applications1–16.	
This	approach	complements	the	currently	available	M13	tool-
set	 and	 provides	 additional	 possibilities	 for	 bottom-up	 bio-
material	 fabrication.	Using	 orthogonal	methods	 to	 organize	
varied	components	onto	such	a	scaffold	in	a	controlled	man-
ner	 is	expected	to	 introduce	new	possibilities	 to	 the	 field	of	
phage-based	bionanomaterials.	 	
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